Onyx Pharmaceuticals, Inc. kohta
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
PeakontorCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Asutatud2013
StaatusAktiivne
Patendid60 patenti
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Logige sisse, et näha kõiki 60 patenti
Sirvige kogu patendiportfelli koos avaldamisnumbrite, kuupäevade ja perekondadega.
Logi sisse Looge konto oma e-posti aadressigaSee on tasuta
Jätkates nõustute Heelky kasutajalepinguga, privaatsuspoliitikaga ja küpsiste poliitikaga.
Arvustused
Arvustusi pole veel. Töötanud ettevõttega Onyx Pharmaceuticals, Inc.? Olge esimene, kes oma kogemust jagab.
Õiguslik teave
| Juriidiline nimi | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Vaata saidil GLEIF ↗ |
| Registreeritud aadress | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Staatus | Aktiivne |
Allikad: GLEIF · uuendatud 16. Oktoober 2026
Kontakt ja lingid
Asukoht
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Kas see on teie ettevõte?
Taotlege seda lehte tasuta, et lisada logo, tooted, fotod ja töökohad ning vastata arvustustele.
Taotle seda lehteLiitu Heelkyga, et luua ühendusi, palgata ja kasvada
Looge tasuta konto, et inimestele kirjutada, töökohtadele kandideerida ja missioone avaldada.
Liitu kohe — see on tasuta